Literature DB >> 18550645

Intrarenal oxygenation: unique challenges and the biophysical basis of homeostasis.

Roger G Evans1, Bruce S Gardiner, David W Smith, Paul M O'Connor.   

Abstract

The kidney is faced with unique challenges for oxygen regulation, both because its function requires that perfusion greatly exceeds that required to meet metabolic demand and because vascular control in the kidney is dominated by mechanisms that regulate glomerular filtration and tubular reabsorption. Because tubular sodium reabsorption accounts for most oxygen consumption (Vo2) in the kidney, renal Vo2 varies with glomerular filtration rate. This provides an intrinsic mechanism to match changes in oxygen delivery due to changes in renal blood flow (RBF) with changes in oxygen demand. Renal Vo2 is low relative to supply of oxygen, but diffusional arterial-to-venous (AV) oxygen shunting provides a mechanism by which oxygen superfluous to metabolic demand can bypass the renal microcirculation. This mechanism prevents development of tissue hyperoxia and subsequent tissue oxidation that would otherwise result from the mismatch between renal Vo2 and RBF. Recent evidence suggests that RBF-dependent changes in AV oxygen shunting may also help maintain stable tissue oxygen tension when RBF changes within the physiological range. However, AV oxygen shunting also renders the kidney susceptible to hypoxia. Given that tissue hypoxia is a hallmark of both acute renal injury and chronic renal disease, understanding the causes of tissue hypoxia is of great clinical importance. The simplistic paradigm of oxygenation depending only on the balance between local perfusion and Vo2 is inadequate to achieve this goal. To fully understand the control of renal oxygenation, we must consider a triad of factors that regulate intrarenal oxygenation: local perfusion, local Vo2, and AV oxygen shunting.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18550645     DOI: 10.1152/ajprenal.90230.2008

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  75 in total

Review 1.  Molecular mechanisms of ischemic preconditioning in the kidney.

Authors:  Pinelopi P Kapitsinou; Volker H Haase
Journal:  Am J Physiol Renal Physiol       Date:  2015-08-26

Review 2.  Pharmacological targets in the renal peritubular microenvironment: implications for therapy for sepsis-induced acute kidney injury.

Authors:  Philip R Mayeux; Lee Ann MacMillan-Crow
Journal:  Pharmacol Ther       Date:  2012-01-16       Impact factor: 12.310

3.  Effects of pH and medullary blood flow on oxygen transport and sodium reabsorption in the rat outer medulla.

Authors:  Jing Chen; Aurélie Edwards; Anita T Layton
Journal:  Am J Physiol Renal Physiol       Date:  2010-03-24

Review 4.  The suffocating kidney: tubulointerstitial hypoxia in end-stage renal disease.

Authors:  Imari Mimura; Masaomi Nangaku
Journal:  Nat Rev Nephrol       Date:  2010-09-28       Impact factor: 28.314

Review 5.  Renal Oxygenation and Hemodynamics in Kidney Injury.

Authors:  Alexander Bullen; Zhi Zhao Liu; Mark Hepokoski; Ying Li; Prabhleen Singh
Journal:  Nephron       Date:  2017-06-15       Impact factor: 2.847

Review 6.  Chronic renal ischemia in humans: can cell therapy repair the kidney in occlusive renovascular disease?

Authors:  Ahmed Saad; Sandra M Herrmann; Stephen C Textor
Journal:  Physiology (Bethesda)       Date:  2015-05

Review 7.  Modeling transport in the kidney: investigating function and dysfunction.

Authors:  Aurélie Edwards
Journal:  Am J Physiol Renal Physiol       Date:  2009-11-04

8.  Preserved oxygenation despite reduced blood flow in poststenotic kidneys in human atherosclerotic renal artery stenosis.

Authors:  Monika L Gloviczki; James F Glockner; Lilach O Lerman; Michael A McKusick; Sanjay Misra; Joseph P Grande; Stephen C Textor
Journal:  Hypertension       Date:  2010-03-01       Impact factor: 10.190

Review 9.  Blood oxygen level-dependent (BOLD) MRI in renovascular hypertension.

Authors:  Monika L Gloviczki; Lilach O Lerman; Stephen C Textor
Journal:  Curr Hypertens Rep       Date:  2011-10       Impact factor: 5.369

10.  In a Phase 1a escalating clinical trial, autologous mesenchymal stem cell infusion for renovascular disease increases blood flow and the glomerular filtration rate while reducing inflammatory biomarkers and blood pressure.

Authors:  Abdelrhman Abumoawad; Ahmed Saad; Christopher M Ferguson; Alfonso Eirin; Sandra M Herrmann; LaTonya J Hickson; Busra B Goksu; Emily Bendel; Sanjay Misra; James Glockner; Allan B Dietz; Lilach O Lerman; Stephen C Textor
Journal:  Kidney Int       Date:  2019-12-13       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.